Eliglustat Reagent Market In Global
Eliglustat is a specific and potent inhibitor of glucosylceramide synthase.
This re ... Read More
Edoxaban is an oral factor Xa (FXa) inhibitor, also contraindicated in patients with active pathological bleeding.
This report contains market size and forecasts of Edoxaban Reagent in global, including the following market information:
Global Edoxaban Reagent Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Edoxaban Reagent Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Edoxaban Reagent companies in 2021 (%)
The global Edoxaban Reagent market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Edoxaban Reagent include Santa Cruz Biotechnology, Biosynth Carbosynth, LGC, ChemScence, Shimadzu, BOC Sciences, APExBIO Technology, Key Organics and KareBay Biochem, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Edoxaban Reagent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Edoxaban Reagent Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Edoxaban Reagent Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Edoxaban Reagent Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Edoxaban Reagent Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Edoxaban Reagent Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Edoxaban Reagent Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Edoxaban Reagent revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Edoxaban Reagent revenues share in global market, 2021 (%)
Key companies Edoxaban Reagent sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Edoxaban Reagent sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Santa Cruz Biotechnology
Biosynth Carbosynth
LGC
ChemScence
Shimadzu
BOC Sciences
APExBIO Technology
Key Organics
KareBay Biochem
Pharmaffiliates
Aladdin
BioCrick BioTech
Eliglustat is a specific and potent inhibitor of glucosylceramide synthase.
This re ... Read More
Eliglustat is a glucosylceramide synthase inhibitor indicated for the long-term treatment of type ... Read More
Eliglustat tartrate is a specific inhibitor of glucosylceramide synthase. It is under development ... Read More
Eliglustat tartrate is a tartrate that is the hemitartrate salt of eliglustat.
This ... Read More